Xcel microarray is built around Affymetrix’ Human Genome U133 Plus 2.0 array. Affymetrix negotiated exclusive distribution rights to Almac Group’s Xcel™ array microarray, which has been developed for ...
OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
Affymetrix adds complementary products in genetic analysis that are used in cytogenetics, genotyping and gene expression. The company’s innovative microarray platform will strengthen Thermo Fisher’s ...
Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...
(Reuters) - A group of former Affymetrix Inc executives offered to buy the gene testing and analysis provider for about $1.5 billion, looking to derail the company's deal with Thermo Fisher Scientific ...
Microarray giant Affymetrix http://www.affymetrix.com of Santa Clara, Calif., is raising the bar for whole-genome association studies. The first in a planned line of ...
the eBioscience portfolio contains comprehensive, innovative and trusted fluorochrome conjugated antibodies and reagents for immunology, oncology, and multicolor flow cytometry, as well as ...
Starwood Bidding War Escalates | ValueAct Pays a Price for Supporting Valeant By Amie Tsang After examining a new offer from Origin Technologies, Affymetrix concluded that Thermo Fisher’s bid, while ...
WASHINGTON, June 4 (Reuters) - A U.S. patent appeals court ruled on Thursday in favor of Agilent Technologies , which had been involved in a patent fight with Affymetrix Inc . The dispute was over ...
Shares of Affymetrix jumped 19 percent Thursday after the Swiss drug firm Roche said it would pay $70 million for a license to use the Santa Clara company's DNA chips to create new ways to diagnose ...
A pioneer in microarray technology and a leader in genomics analysis, Affymetrix now develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results